Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Azria

Showing results (111-120 of 242) with videos related to

Pageof 25
Sort By:
The British Journal of Radiology|July 20, 2021
Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 studyOlivier Chapet, Corina Udrescu, Sylvie Bin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 20, 2024
Radiation-induced lymphocyte apoptosis assay: Primetime for routine clinical use?David Azria, Morgan Michalet, Olivier Riou, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized studyAlain Toledano, Pascal Garaud, Daniel Serin, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2006
Treatment of penile carcinoma: to cut or not to cut?Mahmut Ozsahin, Patrice Jichlinski, Damien C Weber, et al.
Cancer Treatment Reviews|September 20, 2005
Radiation recall: a well recognized but neglected phenomenonDavid Azria, Nicolas Magné, Abderrahim Zouhair, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 2, 2025
Specific features of clinical research in radiotherapy in FranceGilles Créhange, Christophe Hennequin, Benoît Allignet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2016
Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trialsOrazio Caffo, Catherine Thompson, Maria De Santis, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic miceChristel Larbouret, Bruno Robert, Christine Linard, et al.
Radiation Oncology (London, England)|September 20, 2007
Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancerAntoine Serre, Katia Idri, Pascal Fenoglietto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 25, 2008
Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-riskPascal Fenoglietto, Benoit Laliberte, Ali Allaw, et al.
Pageof 25

Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
The British Journal of Radiology|July 20, 2021
Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 studyOlivier Chapet, Corina Udrescu, Sylvie Bin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 20, 2024
Radiation-induced lymphocyte apoptosis assay: Primetime for routine clinical use?David Azria, Morgan Michalet, Olivier Riou, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized studyAlain Toledano, Pascal Garaud, Daniel Serin, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2006
Treatment of penile carcinoma: to cut or not to cut?Mahmut Ozsahin, Patrice Jichlinski, Damien C Weber, et al.
Cancer Treatment Reviews|September 20, 2005
Radiation recall: a well recognized but neglected phenomenonDavid Azria, Nicolas Magné, Abderrahim Zouhair, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 2, 2025
Specific features of clinical research in radiotherapy in FranceGilles Créhange, Christophe Hennequin, Benoît Allignet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2016
Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trialsOrazio Caffo, Catherine Thompson, Maria De Santis, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic miceChristel Larbouret, Bruno Robert, Christine Linard, et al.
Radiation Oncology (London, England)|September 20, 2007
Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancerAntoine Serre, Katia Idri, Pascal Fenoglietto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 25, 2008
Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-riskPascal Fenoglietto, Benoit Laliberte, Ali Allaw, et al.
Pageof 25